根据提供的文献内容，我将按照指定的JSON格式提取并标准化信息。以下是基于《19912990.pdf》文档的信息提取结果：

```json
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.2:c.6059T>C",
                    "cDNA Change": {
                        "transcript": "NM_198578.2",
                        "ref": "T",
                        "alt": "C",
                        "position": "6059"
                    },
                    "Protein Change": {
                        "ref": "I",
                        "alt": "T",
                        "position": "2020"
                    },
                    "Description in input context": "c.6059T>C (p.I2020T)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005072"
    },
    "Experiment Method": [
        {
            "Assay Method": "Transfection of LRRK2 cDNA followed by Western blotting and apoptosis assays",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293, SH-SY5Y",
                "Description": "The experiment was conducted using the HEK293 and SH-SY5Y cell lines."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.2:c.6059T>C",
                    "Conclusion": "Impaired protectivity against apoptosis",
                    "Molecular Effect": "Increased susceptibility to degradation",
                    "Result Description": "I2020T mutant LRRK2 showed impaired protectivity against hydrogen peroxide-induced apoptosis compared to wild-type LRRK2. Prevention of intracellular degradation of I2020T mutant LRRK2 restored its protective effect against apoptosis."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed with multiple cell lines and clones."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each experiment was repeated multiple times."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells were used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Lower percentage of apoptotic cells in WT LRRK2-transfected cells compared to untransfected cells.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Higher percentage of apoptotic cells in I2020T LRRK2-transfected cells compared to WT LRRK2-transfected cells.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明

1. **Variants Include**:
   - 提取了与LRRK2基因相关的变异信息，包括HGVS命名法、cDNA变化和蛋白质变化，并使用相关API进行了标准化。

2. **Described Disease**:
   - 根据文献内容，确定研究的疾病为帕金森病（Parkinson's disease），并通过MONDO数据库检索对应的术语。

3. **Experiment Method**:
   - 列出了文献中提到的所有实验方法，包括材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。
   - **Readout description** 包含所有变异的详细描述，指出了每个变异在实验中的结论和分子效应。

4. **Biological and Technical Replicates**:
   - 描述了生物学和技术重复的情况，确保实验结果的可靠性。

5. **Controls**:
   - 包括了基本的阳性对照和阴性对照，确保实验设计的严谨性。

6. **Statistical Analysis**:
   - 使用了一种常见的统计分析方法（如ANOVA）来验证实验结果。

7. **Thresholds**:
   - 根据文献内容或专业知识确定了正常和异常结果的阈值。

8. **Approved Assay**:
   - 确认所使用的实验方法是否普遍用于研究该疾病。

此JSON格式的信息提取和标准化严格遵循了用户的要求，确保数据的准确性和一致性。